Medical automation is the term for the technology that enables doctors to postpone making diagnoses, encourages better management of many chronic illnesses, and helps lower medical errors. Medical automation, which controls the monitoring, diagnostic, and therapeutic equipment, assists medical professionals in a variety of healthcare facilities with their primary responsive tasks. The pace of technological development in the healthcare sector has significantly accelerated over the past few years. Modern medical automation technology facilitates straightforward, painless disease management. Additionally, improvements in medical automation aid in the precise and speedy diagnosis of diseases. Medical automation innovation also contributes to the affordability of technology-based therapeutic tools used in disease treatment.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-medical-automation-market
Data Bridge Market Research analyses that the Medical Automation Market is valued at USD 44.44 billion in 2022, and will reach USD 92.26 billion by 2030, growing at a CAGR of 9.56% during the forecast period of 2023 to 2030. The increasing global population and growing prevalence of chronic diseases have resulted in a higher demand for advanced and efficient healthcare services. Medical automation technologies help in streamlining processes, reducing errors, and improving overall patient care.
Growing need for precision and personalized medicine is expected to drive the market's growth rate
The growing need for precision and personalized medicine is driven by advancements in genetic testing, molecular diagnostics, and targeted therapies. Medical automation is essential in this context as it enables high-throughput screening, DNA sequencing, and automated laboratory processes. Automating these tasks, medical automation solutions improve the efficiency and accuracy of precision medicine approaches, allowing healthcare providers to deliver personalized treatments based on a patient's unique genetic profile. This automation streamlines processes and enhances the scalability of personalized medicine, making it more accessible and effective for patients.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2023 to 2030
|
Base Year
|
2022
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
Segments Covered
|
Component (Equipment, Software, Services), Type (Automated Prescription Formulation and Dispensing, Automated Health Assessment and Monitoring, Automated Imaging, Automated Healthcare Logistics, Resource and Personnel Tracking, Medical Robotics and Computer-Assisted Surgical Devices, Therapeutic Automation Market, Procedures and Automated Laboratory Testing and Analysis), Application (Diagnostics and Monitoring, Therapeutics, Lab and Pharmacy Automation, Medical Logistics and Training, Others), Connectivity (Wired, Wireless), Distribution Channel (Direct Tender, Retail Sales, Online Sales, Others), End User (Hospitals, Diagnostic Center, Pharmacies, Research Labs and Institutes, Homecare, Specialty Clinics, Ambulatory Surgical Centers (ASCS), Others)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
Market Players Covered
|
Brainlab AG (Germany), Abbott (U.S.), QMeds Inc. (U.S.), HollySys Group (Singapore), SP Automation & Robotics (U.K.), Asahi Kasei Medical Co., Ltd. (Japan), Asteres Inc. (U.S.), ARxIUM (Canada), MedAvail Technologies, Inc. (U.S.), Stereotaxis, Inc. (U.S.), Parata Systems, LLC (U.S.), 3M (U.S.), Accuray Incorporated (U.S.), Intuitive Surgical (U.S.), Medtronic (Ireland), Stryker (U.S.), Cardinal Health (U.S.), Omnicell, Inc. (U.S.), Leica Biosystems Nussloch GmbH (Germany), BD (U.S.), Baxter (U.S.), iCAD Inc. (U.S.), Siemens Healthcare GmbH (Germany), Koninklijke Philips N.V. (Netherlands), GE Healthcare (U.S.), Johnson & Johnson Services, Inc. (U.S.) among others
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The medical automation market is segmented on the basis of component, type, application, connectivity, end user, and distribution channel.
- On the basis of component, global medical automation market is segmented into equipment, software and services. Equipment segment is dominating the market with a CAGR of 12.1% in the forecast period of 2023 to 2030 due to growing number of hospitals, which are significantly affecting on further growing demand of equipment.
In 2023, equipment segment is dominating the component segment of the global medical automation market
In 2023, equipment segment is dominating the market owing to the increasing number of hospitals, which are significantly affecting on further growing demand of equipment with a CAGR of 12.1% in the forecast period of 2023 to 2030.
- On the basis of type, global medical automation market is segmented into automated prescription formulation and dispensing, automated health assessment and monitoring, automated imaging and image analysis, automated healthcare logistics, resource and personnel tracking, medical robotics and computer-assisted surgical devices, automated therapeutic (nonsurgical) procedures, automated laboratory testing and analysis. Automated therapeutic (nonsurgical) procedures segment is dominating the market with a CAGR of 8.5%in the forecast period of 2023 to 2030 due to the rising number of diabetic as well as cardiac patients requiring automated therapeutic devices like insulin pumps and defibrillators for their treatment.
- On the basis of application, global medical automation market is segmented into diagnostics and monitoring, therapeutics, lab and pharmacy automation, medical logistics and training and others. Therapeutics segment is dominating the market with a highest CAGR of 10.0% in the forecast period of 2023 to 2030 due to the increased demand of therapeutics interventions due to the surging cases of chronic disease and advancement in technologies.
- On the basis of connectivity, global medical automation market is segmented into wired and wireless. Wired segment is dominating the market with a CAGR of 8.2% in the forecast period of 2023 to 2030 due to the availability of broad product range in this segment.
- On the basis of end user, global medical automation market is segmented into hospitals, diagnostic center, pharmacies, research labs and institutes, homecare, specialty clinics, ambulatory surgical centers (ASCs). Hospitals segment is dominating the market with a CAGR of 11.7% in the forecast period of 2023 to 2030 due to the prime location visited by patients for diagnosis and treatment of any chronic disease or emergency case.
In 2023, hospitals segment is dominating the end user of the global medical automation market
In 2023, hospitals segment is dominating the end use segment of the global medical automation market owing to their comprehensive range of medical services and the ability to cater to a wide range of patient needs. Diagnostic centers and research labs/institutes may also have a substantial share due to the demand for diagnostic testing and medical research with a CAGR of 11.7% in the forecast period of 2023 to 2030
- On the basis of distribution channel, global medical automation market is segmented into direct tender, retail sales, online sales and others. Direct tender segment is dominating the market with a CAGR of 10.8% in the forecast period of 2023 to 2030 due to growing demand from hospitals and laboratories.
Major Players
Data Bridge Market Research는 의료 자동화 시장의 주요 의료 자동화 시장 참여자로 Brainlab AG(독일), Abbott(미국), QMeds Inc.(미국), HollySys Group(싱가포르), SP Automation & Robotics(영국), Asahi Kasei Medical Co., Ltd.(일본), Asteres Inc.(미국), ARxIUM(캐나다), MedAvail Technologies, Inc.(미국), Stereotaxis, Inc.(미국)를 인식합니다.
시장 개발
- 2023년, Stryker Corporation은 정밀하고 최소 침습적 인공 관절 교체 수술을 가능하게 하는 첨단 수술 로봇 플랫폼인 "Mako SmartRobotics™ 시스템"을 출시하여 정확성과 환자 결과를 향상시켰습니다.
- 2022년, 의료 기술 제공업체인 벡톤, 디킨슨 앤 컴퍼니(Becton, Dickinson and Company)는 최근 파라타 시스템즈(Parata Systems)를 15억 달러에 인수한다고 발표했습니다. 아라타 시스템즈는 재고 관리 소프트웨어, 고속 로봇 디스펜서, 워크플로 및 적합성 포장 도구 등을 제공합니다.
- 2021년, Varian Medical Systems, Inc.는 Siemens Healthineers GmbH에 인수되었습니다. 이로써 Varian Medical Systems는 Siemens Healthineers GmbH의 광범위한 포트폴리오에 대한 접근성을 확대하는 동시에, 독일 의료기기 기업인 Varian Medical Systems의 의료 기술 분야에서의 입지를 더욱 강화하게 되었습니다.
- 2020년, 인도 방사선 및 영상 협회(IRA) 산하 Siemens Healthcare GmbH는 ACUSON Redwood 초음파 시스템을 출시했습니다. 이 기기는 Siemens Healthcare의 새로운 플랫폼 기반에 속하며, 더욱 복잡한 적용 분야를 통해 임상적 신뢰성을 더욱 강화했습니다. 이번 제품 출시를 통해 Siemens Healthcare의 제품 라인과 성장률이 더욱 향상될 것으로 예상됩니다.
- 2000년, 다빈치 수술 시스템은 일반 복강경 수술을 위한 최초의 FDA 승인을 받은 로봇 수술 시스템으로 그 시작을 알렸습니다. 이는 수술 도구와 카메라/내시경 기구를 포함한 포괄적인 시스템이 FDA 승인을 받은 최초의 사례였습니다.
지역 분석
지리적으로 의료 자동화 시장 보고서에서 다루는 국가는 북미의 미국, 캐나다 및 멕시코, 유럽의 독일, 프랑스, 영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽의 기타 유럽, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양(APAC)의 기타 아시아 태평양(APAC), 사우디 아라비아, UAE, 남아프리카 공화국, 이집트, 이스라엘, 중동 및 아프리카(MEA)의 일부인 기타 중동 및 아프리카(MEA), 브라질, 아르헨티나, 남미의 일부인 기타 남미입니다.
Data Bridge Market Research 분석에 따르면:
유럽은 2023년부터 2030년까지의 예측 기간 동안 의료 자동화 시장 에서 주도적인 역할을 할 것입니다.
독일이 유럽 의료 자동화 시장에서 우위를 점할 수 있었던 것은 빠른 기술 발전 덕분입니다. 독일은 혁신과 연구에 집중하여 최첨단 의료 자동화 기술과 솔루션 개발을 이끌어 왔습니다. 독일의 탄탄한 의료 인프라와 디지털화에 대한 집중은 의료 자동화 도입을 더욱 가속화했습니다. 독일의 기술 발전에 대한 헌신과 고품질 의료 시스템이 결합되어 독일은 유럽 의료 자동화 시장의 선두 주자로 자리매김했습니다.
북미는 2023년부터 2030년까지 의료 자동화 시장에서 가장 빠르게 성장하는 지역으로 추정됩니다.
북미 시장에서 미국이 우위를 점하는 데에는 여러 요인이 있습니다. 첫째, 고령 인구 증가와 의료 기관의 자동화 기기 수요 증가가 시장 성장을 견인합니다. 둘째, 미국은 의료 및 정보 기술 분야의 발전으로 유명하며, 이는 의료 자동화 솔루션의 개발 및 도입에 기여합니다. 이러한 요인들은 미국을 시장의 선두 주자로 자리매김하여 의료 산업의 변화하는 요구에 부응하고 있습니다.
의료 자동화 시장 보고서 에 대한 자세한 내용은 여기를 클릭하세요 - https://www.databridgemarketresearch.com/reports/global-medical-automation-market
